Table 1.
Demographic and clinical characteristics of all participants.
| MwoA | HCs | p value | |
|---|---|---|---|
| Age (years) | 33.58 ± 10.88 | 37.26 ± 10.28 | 0.079 |
| Sex (male/female) | 7/48 | 6/44 | 0.910 |
| Education (years) | 12.56 ± 3.10 | 12.20 ± 3.55 | 0.576 |
| Disease duration (years) | 7.22 ± 6.01 | / | / |
| Frequency (days/month) | 4.35 ± 2.53 | / | / |
| HIT-6 score | 59.85 ± 8.96 | / | / |
| VAS score | 6.49 ± 1.35 | / | / |
| GAD-7 score | 6.22 ± 4.58 | / | / |
| PHQ-9 score | 7.38 ± 5.24 | / | / |
| Framewise displacement | 0.22 ± 0.08 | 0.19 ± 0.08 | 0.190 |
| Gray matter (mm3) | 628.31 ± 55.31 | 605.77 ± 55.02 | 0.139 |
| White matter (mm3) | 487.13 ± 43.93 | 496.04 ± 53.40 | 0.351 |
| Brain parenchyma (mm3) | 1115.44 ± 89.60 | 1101.81 ± 92.82 | 0.446 |
Data are presented as mean ± standard deviation. GAD-7: General Anxiety Disorder; HIT-6: Headache Impact Test; PHQ-9: Patient Health Questionnaire; VAS: Visual Analogue Scale; MwoA: migraine without aura; HCs: healthy controls.